Christine A. Shaw
Moderna Therapeutics (United States)
ORCID: 0000-0002-0471-206XPilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness”.
Darin K. Edwards, Sarah R. Leist, Olubukola M. Abiona, Seyhan Boyoglu-Barnum, Rebecca A. Gillespie +57 more
Christine A. Shaw, Gillis R. Otten, Peter W. Mason, Clayton W. Beard, Giulietta Maruggi
Darin K. Edwards, Sarah R. Leist, Olubukola M. Abiona, Seyhan Boyoglu-Barnum, Rebecca A. Gillespie +54 more
Christine A. Shaw, Manju Chandra, Catherine S. Forconi, Ann M. Moormann, Vanaja Konduri +3 more